3A0I
Human glucokinase in complex with a synthetic activator
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PHOTON FACTORY BEAMLINE BL-6B |
Synchrotron site | Photon Factory |
Beamline | BL-6B |
Temperature [K] | 100 |
Detector technology | DIFFRACTOMETER |
Collection date | 2002-04-24 |
Detector | WEISSENBERG |
Wavelength(s) | 1.000 |
Spacegroup name | P 65 2 2 |
Unit cell lengths | 79.732, 79.732, 321.975 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 42.370 - 2.200 |
R-factor | 0.2285 |
Rwork | 0.226 |
R-free | 0.27702 |
Structure solution method | FOURIER SYNTHESIS |
Starting model (for MR) | 1v4s |
RMSD bond length | 0.024 |
RMSD bond angle | 2.060 |
Data reduction software | HKL-2000 |
Data scaling software | WEIS |
Refinement software | REFMAC (5.2.0019) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 2.280 |
High resolution limit [Å] | 2.200 | 2.200 |
Rmerge | 0.064 | 0.254 |
Number of reflections | 30342 | |
<I/σ(I)> | 16.5 | 1.86 |
Completeness [%] | 94.5 | |
Redundancy | 5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 6.6 | 298 | 30 % PEG 1500, HEPES, PH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K |